Dragana Milojkovic

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Treatment-free remission in CML patients with prior TKI failure is not influenced by previous BCR::ABL1 kinase domain mutations.

Treatment-free remission in CML patients with prior TKI failure is not influenced by previous BCR::ABL1 kinase domain mutations.

Journal: British journal of haematology

Published: June 01, 2026

Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFR.

Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFR.

Journal: British journal of haematology

Published: May 06, 2026

ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors.

ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors.

Journal: Leukemia

Published: March 20, 2026

Total body irradiation is associated with increased burden of cerebral microbleeds in haematopoietic stem cell transplant recipients.

Total body irradiation is associated with increased burden of cerebral microbleeds in haematopoietic stem cell transplant recipients.

Journal: British journal of haematology

Published: February 19, 2026

Adapting UK Clinical Practise in Chronic Myeloid Leukaemia in Chronic Phase to Contemporary Management Recommendations: The ADAPT 2.0 Survey.

Adapting UK Clinical Practise in Chronic Myeloid Leukaemia in Chronic Phase to Contemporary Management Recommendations: The ADAPT 2.0 Survey.

Journal: European journal of haematology

Published: February 06, 2026

Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic.

Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic.

Journal: BMJ open

Published: February 05, 2026

Introducing a prognostic score for successful treatment-free remission in chronic myeloid leukaemia.

Introducing a prognostic score for successful treatment-free remission in chronic myeloid leukaemia.

Journal: British journal of haematology

Published: November 21, 2025

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Journal: Leukemia

Published: November 06, 2025

Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Journal: Leukemia

Published: October 30, 2025

Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia: A Systematic Review.

Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia: A Systematic Review.

Journal: Oncology

Published: October 14, 2025

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia.

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia.

Journal: EJHaem

Published: June 30, 2025

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Journal: Leukemia

Published: May 29, 2025

Showing 1-12 of 102

Last Updated: 09/26/2026